Page 1 of 1

Viread for chronic hepatitis B in adults

The FDA ( Food and Drug Administration ) has approved Viread ( Tenofovir disoproxil fumarate ) for the treatment of chronic hepatitis B, a serious liver disease caused by the hepatitis B virus ( HBV ). Chronic hepatitis B is the leading cause of liver cancer worldwide and affects an estimated two mi...
Read Article

Chronic hepatitis B: Viread more effective than Hepsera

Studies 102 and 103 have compared Viread ( Tenofovir disoproxil ) to Hepsera ( Adefovir dipivoxil ) among patients with HBeAg-negative chronic hepatitis B and patients with HBeAg-positive hepatitis B, respectively. Results from both studies show that patients with chronic hepatitis B who received ...
Read Article

Liver transplants can be successful in HIV patients with hepatitis B

A study on HIV patients who also had hepatitis B virus ( HBV ) found that better outcomes are possible if they are referred early for transplant and treated with a combination of drugs for HBV. It is essential to monitor the HBV status of these patients, however, in order to control the emergence ...
Read Article